RecruitingNot ApplicableNCT07397429

Group Therapy Using the "I-Reconstruction" Psychotherapy Method to Reduce Anxiety Levels

Group Therapy Using the I-Reconstruction Psychotherapy Method for Reducing Anxiety Levels: a Randomized Controlled Trial


Sponsor

International Association Psychosomatics And Health Therapy

Enrollment

36 participants

Start Date

Mar 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Brief Summary of the Study The aim of this clinical trial is to find out if the group therapy method "Self-Reconstruction" helps to reduce anxiety in adults. The researchers want to see if the participants' emotional state becomes more stable after completing the course. The main questions that this study aims to answer are: Do people's anxiety levels decrease after taking the course of "I-Reconstruction" classes? Do the positive effects of the classes persist 3, 6 and 12 months after they finish? Do the participants' quality of life and ability to enjoy life improve? The researchers will compare a group of people who attend the therapy classes with a group of people who receive usual care to see if the new method is more effective. Participants will: Participate in 10 online group meetings once a week. Do simple breathing and movement exercises to calm the body and emotions. Discuss your feelings and desires with a professional in a safe group. Complete questionnaires about your condition at the beginning, during, and after the study.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria7

  • Age between 18 and 55 years (inclusive).
  • Clinically significant level of anxiety according to the Beck Anxiety Inventory (BAI) ≥ 9 points.
  • Anxiety subscale score on the Hospital Anxiety and Depression Scale (HADS-A) ≥ 11 points.
  • Significant level of preverbal trauma according to the "Diagnostics of Preverbal Dysregulation" (DPD, T. Pavlenko) questionnaire: total score ≥ 16.
  • Specific subscale scores in DPD: "Desire" ≥ 5, "Satisfaction" ≥ 5, and "Possession" (Obsession) ≥ 6 points.
  • Presence of internal conflicts according to the "Internal Conflict Test" (ICT) ≥ 1 point on the skin tissue measurement scale.
  • Willingness to comply with the study protocol and the online therapy format.

Exclusion Criteria5

  • Current participation in any other psychotherapy during the study.
  • Use of any psychotropic medications within the last 30 days (antidepressants, tranquilizers, neuroleptics, mood stabilizers).
  • Diagnosed severe mental disorders (according to ICD-10/DSM-5) requiring specialized psychiatric care or inpatient treatment.
  • Presence of acute suicidal risk.
  • Substance abuse (alcoholism, drug addiction).

Interventions

DRUGExperimental: Active "I-Reconstruction" Therapy

The intervention consisted of a structured group psychotherapy program based on the "l-Reconstruction" method. The program included ten weekly group sessions, each lasting 120 minutes, delivered online by a certified therapist trained in the method. The intervention targeted anxiety through therapeutic work with preverbal trauma and internal conflicts by reconstructing core personality components related to desire, ownership, and the capacity for pleasure. The therapeutic process combined psychoeducation, analysis of preverbal acts, exploration of emotional and bodily responses, reconstruction of traumatic experiential patterns, and structured group reflection and integration. The intervention followed a standardized protocol to ensure consistency across groups and therapists.

DRUGStandard Care (Treatment as Usual)

Participants assigned to the control group did not receive any structured psychotherapeutic intervention as part of the study. During the intervention period, no active treatment, group sessions, or therapeutic procedures were provided by the research team. The control condition was designed to serve as a non-intervention comparison group for evaluating the effects of the "l-Reconstruction" group psychotherapy.


Locations(1)

International Association of Psychosomatics and Body Therapy

Kyiv, Kyiv Oblast, Ukraine

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07397429


Related Trials